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Objectives: Neonates admitted to Neonatal Intensive Care Units (NICU) are at significant risk of 23 
developing bloodstream infections (BSIs). Gram-negative bacteria (GNB) both colonise and infect, but 24 
the association between these entities is unclear. By conducting a systematic literature review, we 25 
aimed to explore the impact of factors on the association between GN colonisation and GN-BSI at both 26 
baby level and unit level. 27 
Methods: We searched Medline, Embase, and Cochrane Library. Observational cohort studies 28 
published after 2000 up to June 2016 reporting data on the total number of neonates (0-28 days) 29 
colonised with GNB assessed by rectal/skin swab culture and the total number of neonates with GN-30 
BSI (same bacteria) were included. Studies were excluded if data on skin/rectal colonisation, neonates, 31 
and GNB could not been identified separately. The meta-analyses along with multivariate meta-32 
regression with random-effect model were performed to investigate factors associated with the GN 33 
colonisation and GN-BSI at baby-level and unit-level.  34 
Results: 27 studies fulfilled our inclusion criteria, 15 for the baby-level and 12 for the unit-level 35 
analysis. Study heterogeneity was high, with suboptimal overall quality of reporting assessed by the 36 
STROBE-NI statement (44.8% of items adequately reported). In 1,984 colonised neonates, 157 (7.9%) 37 
developed GN-BSI compared with 85 of 3,583 (2.4%) non-colonised neonates. Considerable 38 
heterogeneity across studies was observed. Four factors were included in the meta-regression model: 39 
Gross domestic product (GDP), pathogen, outbreak, and frequency of screening. There was no 40 
statistically significant impact of these factors on GN colonisation and GN-BSI in baby level. We were 41 
unable to perform the multivariate meta-regression due to the insufficient reported data for unit level.   42 
Conclusions: Study limitations include the small number and the high heterogeneity of the included 43 
studies. While this report shows a correlation between colonisation and BSI risk, this data currently 44 
doesn’t support routinely screening for GNB. The analysis of large cohorts of colonised neonates with 45 
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clinical outcomes is still needed to define the major determinants leading from colonisation to 46 




Babies admitted to Neonatal Intensive Care Unit (NICU) are at high risk of developing bloodstream 49 
infections (BSIs) and have been identified as a critical population for the acquisition and transmission 50 
of multidrug-resistant (MDR) pathogens.[1] Among them, Gram-negative bacteria (GNB) are of highest 51 
concern in the neonatal population, with a global increase in the incidence rate and very limited 52 
therapeutic options.[2] MDR-GNB have been found to be responsible for an increasing number of 53 
NICU outbreaks, with many implications for infection control policies and practices, and mortality 54 
rates reported around 30%.[3]  55 
GNB can cause both colonisation and infections. In a colonised patient, the organism is found on the 56 
body but is not causing any symptoms or disease. At birth, healthy neonates have no endogenous 57 
microflora which is rapidly acquired through perinatal transfer of maternal vaginal and gastrointestinal 58 
flora (vertical transmission) and from environmental or human sources (horizontal transmission).[4] 59 
However, sick neonates who require prolonged hospitalisation are at high risk of colonisation with 60 
resistant or difficult-to-treat bacteria as a result of intense and long-term exposure to antibiotics and 61 
the hospital environment.[5, 6] Some studies have shown a positive association between gut 62 
overgrowth and neonatal sepsis.[7, 8] Studies conducted during hospital outbreaks are broadly 63 
consistent in showing a relationship between the microorganisms causing colonisation and those 64 
isolated from the blood cultures of septic neonates admitted to the same unit.[9] However, the 65 
mechanisms leading from colonisation to infection are still debated. 66 
Screening for colonisation is usually discussed in the context of intensive care to prevent cross-67 
infections and inform strategies, such as patient cohorting.[10] However, role of active surveillance 68 
for GNB in informing antimicrobial empirical treatment has not yet been fully explored and evaluated 69 
in neonates. Clarifying the link between GNB colonisation and infection might have a significant impact 70 
on the clinical management for hospitalised babies. If a link is demonstrated, carriage screening could 71 
potentially be used to stratify patients to different antibiotic regimens and, at the same time, to select 72 
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baseline treatment options at unit-level and potentially conserve broad spectrum antibiotics. By 73 
conducting a systematic literature review, we aimed to explore the impact of factors on the 74 
association between GN colonisation and GN-BSI at both baby level and unit level. 75 
 76 
METHODS 77 
A review protocol is available upon request. Studies were considered eligible for inclusion if reporting 78 
data on neonates aged 0-28 days (Population), rectal swab/stool culture or skin swab culture to assess 79 
GN colonisation (Intervention), comparing the prevalence of GN-BSI among colonised and non-80 
colonised neonates (Comparison), considering GN-BSI as clinical outcome (Outcome), in neonates 81 
admitted to NICU (Setting). The search was limited to studies published after 2000. Given the advances 82 
in modern neonatology, the aim was to capture publications that reflect policies and practices over 83 
the last 15 years. No language restriction was applied. 84 
Medline (Ovid MEDLINE(R) without Revisions 1996 to June Week 2 2016), Embase (Embase 1996 to 85 
2016 Week 24), and Cochrane Library (Issue 6 of 12, June 2016) databases were systematically 86 
searched on June 15, 2016 with a strategy combining MeSH and free text terms for “neonate” AND 87 
“colonisation” AND “bloodstream infection”. The full strategy is available as Supplementary Material. 88 
Two assessments for included studies were performed. In the first one (baby-level) inclusion criteria 89 
for studies were their reporting of: 1) data on neonates aged 0-28 days, 2) the total number of babies 90 
colonised with GNs assessed by rectal swab/stool culture or skin swab culture, and 3) the total number 91 
of GN-colonised babies who developed a concordant (caused by the same pathogen) GN-BSI. In the 92 
second assessment (unit-level), inclusion criteria were studies reporting: 1) data on neonates aged 0-93 
28 days, 2) the total number of babies colonised with GNs assessed by rectal swab/stool culture or 94 
skin swab culture during the study period, and 3) the total number of babies with GN-BSI in the same 95 
unit during the same timeframe were considered eligible for inclusion. Studies were excluded if 96 
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reporting data on multiple colonisation sites but rectal and/or skin colonisation data could not be 97 
identified; studies also including children and/or adults where neonatal data could not be clearly 98 
extracted; and studies reporting data on both Gram positives and GNs if GN data could not be 99 
identified separately.  100 
The primary outcome was to investigate the variables with an impact on the association between GN 101 
colonisation and GN-BSI at both baby-level and unit-level.  102 
Data on study characteristics, demographic and clinical features of included neonates, inclusion and 103 
exclusion criteria, outcome definitions, microbiological methods, and total numbers of 104 
colonised/infected babies was independently extracted by two different authors (LF and CT), 105 
according to pre-specified criteria. In case of disagreements, these were resolved in discussion with a 106 
third author (JB). 107 
This study did not receive any direct funding. 108 
Quality assessment 109 
To assess the quality of the included studies, the Newcastle-Ottawa scale was used (Table S1).[11] 110 
Moreover, to assess the quality of reporting of the included studies, the recently published 111 
Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-112 
NI) statement was used.[12] This checklist is an extension of the STROBE statement aiming to improve 113 
scientific reporting of neonatal infection studies, with the ultimate goal to increase data utility and 114 
allow meta-analytical approaches. The proportion of STROBE-NI items adequately reported was 115 
calculated for each study. This review complies with the PRISMA guideline.[13] 116 
Statistical analysis 117 
The proportion of concordant GN-BSI in colonised babies was calculated as number of 118 
infections/colonised babies. Colonisation pressure was calculated as number of colonised babies/total 119 
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NICU admissions in the study period. The proportions of colonisation and infections were calculated 120 
using the crude data collected as the number of colonised or infected babies/total number of neonates 121 
admitted during the study period.  The two-tailed Mann-Whitney U test for two independent samples 122 
was used to compare the STROBE-NI score between studies primarily designed for clinical and those 123 
mainly for microbiological purpose. A p-value of less than 0.05 was considered statistically significant.  124 
We performed a sub-group meta-analysis along with multivariate meta-regression.[14, 15] Study 125 
characteristics extracted for sub-group and meta-regression were: 1) gross domestic product (GDP) 126 
(upper-middle-income countries (UMIC), lower-middle-income countries (LMIC), high-income 127 
countries (HIC)); 2) pathogen (Klebsiella spp. vs other Gram-negative pathogens); 3) screening timing 128 
(once vs twice a week); 4) outbreak (study carried out during outbreak vs not during outbreak).  We 129 
carried out baby-level and unit-level meta-analyses separately. For baby-level, the meta-analysis was 130 
conducted to produce estimated risk ratio (RR) as the measure of group difference (colonisation vs 131 
non-colonisation) on the rate of infection. Due to the insufficient data reported for unit-level, we used 132 
the Freeman-Tukey double arcsine transformation (arcsine square root transformation [16]) to 133 
calculate the weighted proportion of overall infection rate. We performed the DerSimonian and Laird 134 
random-model effect using inverse variance weight method, which takes into account the within study 135 
variation and between study heterogeneity. The I2 statistic was used to describe the variation across 136 
studies due to heterogeneity. We defined the level of heterogeneity as low, moderate, and high 137 
correspond to I2 values of 25%, 50%, and 75%.[14] As the small number of included studies, we were 138 
unable to carry out publication bias in this present study.[14] The meta-analysis and meta-regression 139 





Study selection and description 143 
The search identified 8,543 studies. Among them, 25 papers and 2 conference abstracts fulfilled our 144 
inclusion criteria and were included in the final analysis. 5,254 studies were excluded based on the 145 
title, 1,338 were rejected on abstract, and 211 were rejected on full text (Figure 1). 15 studies were 146 
selected for the baby-level[4, 6, 8, 17-28] and 12 for the unit-level analysis.[9, 29-39] 18 out of 27 147 
studies were carried out in high-income countries (HIC),[4, 6, 8, 18, 20, 22-24, 26-28, 30-32, 34-37] 5 148 
in upper middle-income countries (UMIC),[17, 19, 21, 25, 29] and 2 in lower middle-income countries 149 
(LMIC)[9, 33], according to the 2016 World Bank Classification (Table 1S).[40] 20 were carried out as 150 
prospective[4, 6, 8, 9, 18, 20-22, 25-33, 35, 36, 38] and 5 as retrospective studies.[17, 19, 23, 34, 37] 151 
Two papers did not provide their study design.[24, 39] 8 studies were carried out during hospital 152 
outbreaks.[21, 24, 28-31, 37, 38]  153 
Apart from one study,[23] all papers assessed colonisation through rectal swab or stool culture (Table 154 
2S). 24 (88.9%) out of 27 studies provided information about timing and frequency of microbiological 155 
screening.[4, 6, 8, 9, 17-36] In nearly half of the studies, rectal/skin swabs were performed weekly 156 
through the baby’s NICU stay[4, 6, 17, 19, 20, 24-30, 32, 33] whereas in 6 studies neonates were 157 
screened twice a week.[8, 21, 22, 31, 35, 36]  158 
To evaluate the concordance between colonising and bloodstream isolates, 15 (55.6%) out of 27 159 
studies performed genotyping analyses.[4, 9, 20-22, 24, 25, 28-32, 35, 37, 39] Twelve studies 160 
genotyped the isolates by pulsed field gel electrophoresis (PFGE)[4, 9, 20, 25, 28-32, 35, 37, 39] 161 
whereas 3 studies performed Polymerase Chain Reaction (PCR).[21, 22, 24] Only one study assessed 162 
the genotype by sequencing the pathogens.[39]  163 
Only one study assessed the cost-effectiveness of the intervention.[30] 164 
Quality assessment of included studies 165 
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A huge variation was highlighted in terms of study design (prospective vs retrospective, inclusion 166 
criteria, different outcomes assessed), included population (gestational age, birth weight, sample 167 
size), and investigated pathogens (different strains, different resistance pattern). Overall, according to 168 
the STROBE-NI checklist,[12] the included studies reported adequately a mean of 44.8% (range 8.6-169 
67%) of the suggested items. A statistically significant difference was highlighted in terms of 170 
compliance with the checklist between studies primarily designed for clinical and those mainly for 171 
microbiological purposes (47.2% vs 32.4%, p=0.034). As summary considerations on study quality in 172 
general, according to the Newcastle-Ottawa scale, all studies assessed the exposure and the outcome 173 
by using secure records, and all of them selected the non-exposed cohort from the same community 174 
as the exposed cohort. However, very few studies demonstrated that the outcome of interest was not 175 
present at the start of the study and none of them reported a statement about proportion of patients 176 
who completed the follow-up (Table 1S). 177 
Baby-level analysis 178 
15 studies were included in the baby-level analysis,[4, 6, 8, 17-28] 3 (20.0%; 3/15) of which were 179 
carried out during NICU outbreaks.[21, 24, 28] 7 (46.7%; 7/15) studies provided information about 180 
demographic characteristics of the included cohort (e.g. age at screening, birth weight or gestational 181 
age) (Table 3S).[4, 6, 8, 19, 22, 25, 26] The length of follow-up was reported in 6 studies.[6, 22, 24-26, 182 
28] Five studies reported the interval between colonization and onset of concordant BSI.[8, 13, 16, 21-183 
22]  184 
Overall, a total of 8,421 neonates were screened for rectal and/or skin colonisation. Among them, 185 
1,984 (23.6%) were found to be colonised by GNB. In total, 157 colonised babies experienced a BSI 186 
concordant with the colonising pathogen (7.9%). A broad variation was found among the included 187 
studies in terms of prevalence of concordant GN-BSIs in colonised babies (range 0.0 – 42.8%). In those 188 
studies that also reported the number of non-colonized babies who developed a GN-BSI, the 189 
proportion of neonates who experienced a GN-BSI was 2.4% (85/3,583).  190 
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Only one study reported the relatedness between the genotype of colonising and invasive pairs of 191 
isolates.[20] In this study, 17 out of 19 strains (89.0%) had an indistinguishable PFGE pattern.    192 
Meta-analysis  193 
All sub-group meta-analyses results are shown in Figure 2. The random-effects inverse variance meta-194 
analysis for all sub-groups demonstrated strong evidence of heterogeneity within sub-groups, and 195 
heterogeneity between sub-groups. The overall estimated RRs in within sub-groups analyses did not 196 
show any differences for GDP, pathogen, and outbreak. However, when conducting separate meta-197 
analysis for screening frequency , RR of GN-BSI in babies screened twice/week compared with once a 198 
week was 1.24 (95CI: 1.12-1.37) in the non-colonisation group and 0.95 (95%CI: 0.94-0.97) in the 199 
colonisation group. I-squared (I2) estimates of 75.5% (screening twice) and 64.2% (screening once) 200 
showed a different heterogeneity to the overall meta-analysis. To further explore heterogeneity 201 
between studies, we performed multivariate meta-regression analysis (Table 1). All included variables 202 
in the meta-regression analysis did not show statistically significant impact on GN colonisation and 203 
GN-BSI in the baby-level.  204 
Unit-level analysis 205 
12 studies were included for the analysis at the unit-level,[9, 29-39] 5 (41.6%) of which were carried 206 
out during outbreaks in the neonatal units.[29-31, 37, 38]  207 
A total of 6,363 babies were included. Among them, 1,825 neonates (28.7%) had a rectal/skin swab 208 
positive for GNB (Table 2). The colonisation pressure varied widely among the selected studies, 209 
ranging from 1.0%[34] to 81.8%.[9] Overall, the prevalence of GN-BSIs among neonates admitted to 210 
the NICUs during the same timeframe was 8.1% (516 BSI episodes/6,363 admitted babies). The rate 211 
of BSIs among the different studies ranged from 0.0 to 19.8%.   212 
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In those studies evaluating the molecular epidemiology among colonising and invasive strains, PFGE 213 
analysis proved to be a very useful tool to investigate the spread and clonality of isolated pathogens, 214 
especially in the context of NICU outbreaks.[9, 29-32, 35, 37, 39]   215 
Meta-analysis  216 
The sub-group meta-analyses results for unit-level are shown in Figure 1S. Results for all within sub-217 
group analyses have shown considerable high heterogeneity. This may be due to the insufficient 218 
reported data in the included studies. In addition, we were unable to perform the multivariable meta-219 
regression model from the available unit-level data.  220 
 221 
DISCUSSION 222 
This systematic review included 27 studies, 15 were included in the baby-level and 12 in the unit-level 223 
analysis. The quality of reporting assessed by the STROBE-NI statement’s checklist was suboptimal in 224 
the great majority of the published studies, with a significant difference between those primarily 225 
targeting clinical research questions and those focusing on microbiological research questions. Eight 226 
studies were carried out during NICU outbreaks. A total of 14,784 babies were screened for gut or skin 227 
colonisation. Among babies that were colonised, 7.9% developed a concordant BSI. The overall 228 
estimated RRs within sub-groups were similar for GDP, pathogen, and outbreak. In addition, the 229 
within-group I2 estimates for these factors were similar. However, the RRs of GN-BSI comparing twice 230 
weekly with weekly screening were 1.24 in the non-colonisation group and 0.95 in the colonisation 231 
group with different I2 estimates. To explore this further, meta-regression analyses were carried out. 232 
None of these factors were statistically significant associated with GN colonisation and GN-BSI at the 233 
baby-level. Only one study analysed the genotypic relatedness of colonising and invasive pairs of 234 
isolates. Due to the insufficient reported data for unit-level, we were not able to further explore the 235 
association of these factors and the outcome of interest in present study. 236 
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Many studies over the last decade have tried to assess the association between gastrointestinal (GI) 237 
bacterial flora and the onset of invasive infection in neonates. Direct translocation of bacteria from 238 
the GI tract to the bloodstream through immature or damaged bowel wall (such as in case of 239 
necrotizing enterocolitis) and indirect transfer via other pathways due to immaturity of defence 240 
mechanisms are some of the hypotheses that have been suggested.[7] Many factors associated with 241 
the NICU stay, both environment- and patient-related, have been shown to influence the status of the 242 
neonatal microbiome, therefore predisposing high-risk babies to nosocomial infections.[5]     243 
Treatment with broad-spectrum antibiotics, frequently experienced by hospitalised neonates,[41] 244 
leads to gut colonisation with multidrug-resistant Gram-negative bacteria (MDRGN) by selecting 245 
resistant flora.[42] The GI tract provides an important reservoir for antibiotic-resistant GNB that can 246 
then persist throughout the NICU stay and can be easily transmitted between patients.[43] 247 
The individual-level association between colonisation and BSI we observed may actually explain their 248 
ecological association at unit-level. For the unit-level analysis, we were unable to determine whether 249 
colonisation preceded infection in affected babies. However, there may be an additional impact of 250 
cross-infections with rapid transition from colonisation to invasive infection in the face of high 251 
colonisation pressure. Recently, colonisation pressure has been identified as an independent risk 252 
factor for ICU-acquired MDR-infections in adults.[44]  253 
Conversely, the role of carriage screening to adjust empirical regimens in colonised patients in the 254 
non-epidemic setting has not been properly explored yet. Screening may have a particularly important 255 
role in NICUs, to closely monitor high-risk neonates, to inform empirical treatment when resistance 256 
patterns are identified, and to set up preventive interventions, such as decolonisation and 257 
decontamination, to reduce the risk of invasive infections.[45] Such potential interventions have to be 258 
interpreted in the light of a recent review of the interventions to control neonatal healthcare-259 
associated infection outbreaks, which showed that enhanced swab-based surveillance did not prove 260 
to be effective at reducing case-fatality or outbreak duration.[46]  261 
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Our review showed the different RRs associated with the frequency of screening (once vs twice a 262 
week) in the infection rate of subsequent BSI in non-colonised and colonized babies. Despite the 263 
multivariate meta-regression failing to demonstrate a statistically significant finding for this factor, the 264 
screening time plays an important role in the clinical practice. A strategy of continuous surveillance of 265 
MDRGN colonization has been discussed extensively, both as a basis for preventing cross-infection 266 
and to facilitate infection control measures.[47] However, there is no consensus on the optimal timing 267 
and frequency of ongoing screening. 268 
The predictive value of rectal MDRGN colonisation for subsequent MDRGN bacteraemia has been 269 
assessed in a number of studies in adults, with variable findings. Due to the significant implication of 270 
these highly resistant infections on healthcare costs and patients outcomes, the need to develop 271 
clinical prediction algorithms to identify patients potentially colonised with such organisms (and 272 
therefore candidates for screening) at hospital admission has been broadly recognised.[48]  273 
At the moment, the cost-effectiveness of routine rectal screening cannot be fully elucidated. Frequent 274 
delays in laboratory reporting of microbiological results and increased exposure to broad-spectrum 275 
antibiotics are some of the potential limits for supporting colonisation-guided versus standard empiric 276 
antibiotic treatments. Without clear evidence of a significant impact on patient outcome, the 277 
implementation of routine surveillance cultures in those setting where MDRGNs are rare or endemic 278 
might not be warranted. 279 
This review has several limitations. Firstly, the association between GNB colonisation and GN-BSI in 280 
neonates must be interpreted in the light of the small number of included studies and the high 281 
heterogeneity in terms of study design, included population, and investigated pathogens. Due to the 282 
low number of studies included in the meta-analysis, we were unable to assess publication bias. 283 
Different pathogens have been shown to have different impacts on the risk of developing invasive 284 
infections in colonised neonates, and pooling data on multiple strains could have biased the 285 
results.[42] Lastly, the quality of data reporting was assessed according to the STROBE-NI statement 286 
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checklist. However, this guideline was designed to improve the reporting of observational studies on 287 
the epidemiology of neonatal infections, and may not have been entirely suitable for some of the 288 
studies included in this review primarily designed for microbiological purpose. However, this is the 289 
only specific guidance currently available for the reporting of neonatal infections.  290 
The analysis of large prospective cohorts of colonised neonates with their clinical outcomes is highly 291 
relevant in order to clarify the risk factors and determinants for invasive infections. This is evident 292 
from the observation that although we showed a correlation between colonisation and invasive 293 
disease, the majority of colonised babies do not develop systemic invasive infection. Previously 294 
published studies did not attempt to link WGS data with clinical outcome nor to ascertain the 295 
relatedness between colonising and invasive pathogens. Such information could assist in gaining 296 
evidence on pathogenicity determinants and might have a significant impact on the management of 297 
neonates with GN-BSIs. If a correlation between gut colonisation and invasive infections is confirmed, 298 
easy-to-collect rectal swab data could be used as a proxy, at the patients- or NICU-level, to inform 299 
empirical antibiotic treatment in neonates with suspected BSIs. In the LMIC setting, blood cultures are 300 
infrequently obtained from neonates, thus readily obtained rectal swabs could be used as a predictor 301 
of MDR pattern at unit-level and help identify the optimal antibiotic regimens to be used. In HIC, 302 
demonstrating a correlation between colonisation and invasive infections might help define the best 303 
strategies for Infection Prevention and Control (e.g. cohorting babies during hospital outbreaks) and 304 
to select babies who would benefit most from broad-spectrum antibiotics (for targeted clinical 305 
management) and those who can receive more narrow-spectrum antibiotics.   306 
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Table 1: Meta-regression to determine the factors that account for the heterogeneity between studies in the baby-level  
Variable Coefficient p-value 95%CI lower 95%CI upper 
Screening timing 0.197 0.594 -3.193 3.589 
GDPa classification -0.273 0.417 -2.939 2.392 
During outbreak (Y/N) 0.275 0.412 -2.370 2.921 
Pathogen -0.266 0.422 -2.910 2.378 
aGDP: Gross domestic product   
23 
 
Table 2: Colonisation pressure and rate of Bloodstream Infections in studies included in the unit-level analysis 
Author, year Population (n of  
screened babies) 
N of colonised babies Colonisation pressure (%) N of infected babies  
(in the same period) 
BSI rate (%) 
Cassettari VC, 2009 [29] 120 27 22.5 7 5.8 
Das P, 2011 [9] 242 198 81.8 32 13.2 
Gbaguidi-Haore H, 2008 [30] 735 166 22.6 29 3.9 
Gupta A, 2004 [31] 73 14 19.2 6 8.2 
Haase R, 2014 [32] 635 27 4.3 4 0.6 
Litzow JM, 2009 [33] 1,831 1,017 55.5 358 19.6 
Macnow T, 2013 [34] 1,475 15 1.0 8 0.5 
Mammina C, 2007 [35] 210 116 55.2 25 11.9 
Parm U, 2011 [36] 276 154 55.8 27 9.8 
Rettedal S, 2013 [37] 469 58 12.4 1 0.2 
Richards C, 2004 [38] 69 8 11.6 0 0.0 
Roy S, 2010 [39] 228 25 11.0 19 8.3 

















Figure 1: Flowchart and study selection 
Figure 2: Random effects meta-analysis for estimated risk ratio at the baby-level by groups 
(Abbreviations: CI, confident interval; RR, risk ratio; HIC, high income country; UMIC, upper middle income 
country) 
Figure 1S: Random effect meta-analysis for infection rate at the unit-level by groups 
 
